Catalyst Wire Dossier Catalyst Wire Dossier

Dipeptide N(2)-L-Alanyl-L-Glutamine

L-alanyl-L-glutamine dipeptide
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dipeptide N(2)-L-Alanyl-L-Glutamine, covering 2010-12-01 to 2010-12-01. Get the full timeline:

Most recent: Clinical Trial Update: Effectiveness of Dipeptide N (2)-L-Alanyl-L-Glutamine in Trauma ICU Patients: Pilot, Prospective, Randomized and Double Blind Study. [Phase 2]

See pricing